HESHAM MOHAMED to Immunotherapy, Adoptive
This is a "connection" page, showing publications HESHAM MOHAMED has written about Immunotherapy, Adoptive.
Connection Strength
0.152
-
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study. Blood. 2025 Apr 03; 145(14):1498-1509.
Score: 0.152